These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The single-dose bioavailability of different lithium carbonate products. Tsang HY; Chen CC; Wen JK Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):543-8. PubMed ID: 3114414 [No Abstract] [Full Text] [Related]
9. Evaluation of a slow-release lithium carbonate formulation. Cooper TB; Simpson GM; Lee JH; Bergner PE Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833 [TBL] [Abstract][Full Text] [Related]
10. Dissolution and saliva concentrations of some lithium dosage forms. Wall BP; Parkin JE; Sunderland VB; Zorbas A J Pharm Pharmacol; 1982 Sep; 34(9):601-3. PubMed ID: 6127391 [No Abstract] [Full Text] [Related]
11. Absorption & urinary & salivary excretion of lithium after oral administration. Doshi BS; Rout SJ; Kulkarni RD Indian J Med Res; 1983 Nov; 78():708-12. PubMed ID: 6423533 [No Abstract] [Full Text] [Related]
12. [Bioavailability of lithium from tablets containing different lithium salts]. Leucuţa S; Fodoreanu L; Pop R; Barna D; Kovãcs A Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(2):145-8. PubMed ID: 6216569 [No Abstract] [Full Text] [Related]
13. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man. Caldwell HC; Westlake WJ; Connor SM; Flanagan T J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514 [No Abstract] [Full Text] [Related]
14. Aspect of the pharmacokinetics of slow-release lithium carbonate. Hart GA S Afr Med J; 1984 Aug; 66(5):178-9. PubMed ID: 6431618 [TBL] [Abstract][Full Text] [Related]
15. [Preformulation study of controlled release nitrofurantoin preparations. 2]. Marton S; Nguyen Thi Minh Tam ; Antal I; Rácz I Acta Pharm Hung; 1990 May; 60(2-3):57-67. PubMed ID: 2386073 [TBL] [Abstract][Full Text] [Related]
16. Single dose pharmacokinetics of a controlled release lithium preparation "Liskonum" in African patients suffering from manic depressive psychosis. Mengech HN; Ojwang PJ East Afr Med J; 1984 Apr; 61(4):321-5. PubMed ID: 6489236 [No Abstract] [Full Text] [Related]
17. Single-dose bioavailability of two extended-release lithium carbonate products. Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of whole and half Theo-Dur tablets. Fagerström PO Eur J Respir Dis Suppl; 1980; 109():62-6. PubMed ID: 6934089 [TBL] [Abstract][Full Text] [Related]
19. [Serum lithium levels after slow-release and regular tablets of lithium carbonate]. Kauko K; Viukari M Duodecim; 1973; 89(19):1324-8. PubMed ID: 4757404 [No Abstract] [Full Text] [Related]
20. Per-oral controlled release dosage form of theophylline using soybean protein. Machida Y; Tokumura T; Nagai T Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]